Kristine Peterson insider trades: ImmunoGen (IMGN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kristine reports to the SEC
and 3 more companies
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | IMGN | ↓ Sell | 20,000 | $28.90 | $578K | Direct | Dec 5, 2023 (5d) |
| Feb 22, 2019 | AMRN | ↓ Sell | 163,500 | $20.02 | $3.3M | Direct | Feb 22, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kristine Peterson's insider trades
Kristine Peterson is a director at ImmunoGen (IMGN). Since Feb 22, 2019, Kristine has reported no open-market purchases and 2 sales worth $3.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (52 filings), option exercises (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.